AngioDynamics, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
ANGO Nasdaq 3841 http://www.angiodynamics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AngioDynamics, Inc.

The Daily Biotech Pulse: Hookipa To Debut, Mustang Bio Skyrockets, AngioDynamics Sheds Portfolio - Apr 18th, 2019 5:42 am
AngioDynamics will sell Namic business for $167.5 million - Apr 17th, 2019 5:37 pm
AngioDynamics Announces Agreement to Sell NAMIC® Fluid Management Business to Medline Industries, Inc. for $167.5 Million - Apr 17th, 2019 2:05 pm
Why AngioDynamics, Inc.’s (NASDAQ:ANGO) Return On Capital Employed Might Be A Concern - Apr 17th, 2019 10:13 am
AngioDynamics’ DIRECT Clinical Study Receives Institutional Review Board Approval for the Treatment of Stage III Pancreatic Cancer - Apr 17th, 2019 6:01 am
Edited Transcript of ANGO earnings conference call or presentation 2-Apr-19 12:00pm GMT - Apr 10th, 2019 6:57 am
AngioDynamics' (ANGO) Q3 Earnings & Revenues Lag Estimates - Apr 3rd, 2019 8:32 am
AngioDynamics (ANGO) Q3 2019 Earnings Conference Call Transcript - Apr 2nd, 2019 6:45 pm
AngioDynamics Gets FDA Nod to Begin NanoKnife DIRECT Study - Apr 2nd, 2019 8:20 am
AngioDynamics (ANGO) Lags Q3 Earnings and Revenue Estimates - Apr 2nd, 2019 6:15 am
AngioDynamics: Fiscal 3Q Earnings Snapshot - Apr 2nd, 2019 5:09 am
AngioDynamics Reports Fiscal 2019 Third Quarter Financial Results - Apr 2nd, 2019 5:00 am
AngioDynamics, Inc. to Host Earnings Call - Apr 2nd, 2019 4:00 am
AngioDynamics to Present at the Needham Healthcare Conference - Apr 1st, 2019 2:01 pm
AngioDynamics Receives FDA Approval to Initiate NanoKnife® DIRECT Clinical Study for the Treatment of Stage III Pancreatic Cancer - Apr 1st, 2019 4:00 am
CORRECTING and REPLACING OARtrac® Radiation Dose Monitoring System Receives Expanded FDA Clearance for Electron Radiation Therapy - Mar 28th, 2019 4:48 pm
Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for - Mar 26th, 2019 8:30 am
AngioDynamics to Report Fiscal 2019 Third Quarter Financial Results on April 2, 2019 - Mar 12th, 2019 2:01 pm
Avanos (AVNS) Q4 Earnings Beat, Revenues Miss, Shares Down - Mar 12th, 2019 8:58 am
The AngioDynamics (NASDAQ:ANGO) Share Price Has Gained 88% And Shareholders Are Hoping For More - Mar 11th, 2019 12:02 pm